Schizophrenia and Psychoses Archive
Although all-cause pharmacy costs were higher in the paliperidone palmitate group, adjusted all-cause medical costs were lower.
Use of virtual reality environments in which participants interact with computer-controlled situations or avatars enables a more fine-tuned approach to exposure in the context of cognitive behavioral therapy.
A combination of an SSRI and antipsychotics in a clinical setting most likely does not lead to a further deterioration of metabolic variables to a clinically significant degree.
tDCS may be an important tool for further improving our understanding of psychosis and designing targeted treatments.
Researchers examined which atypical antipsychotic was more effective and safe in first-episode drug-naive schizophrenia.
A meta-analysis of randomized, controlled trials compared the use of benzodiazepines alone or in combination with antipsychotic or antihistamine medications in patients experiencing acute psychotic illness.
Investigators seek the association between psychosis and complication risk after total joint arthroplasty.
P50 processing may inform researchers in the future development of interventions targeting cognitive impairment in schizophrenia.
All patients with a substance-induced psychosis should be offered follow-up.
This research suggests that interventions to improve cognitive insight may bolster neurocognition in schizophrenia.
Investigators seek the association between the risk of developing schizophrenia and advanced maternal and paternal age.
Gender differences may predict the types of symptoms and age of onset of schizophrenic psychosis.
Investigators assessed biomarkers for cardiovascular risk and protection in individuals with first-episode psychosis.
Investigators believe social recovery therapy may benefit individuals with complex comorbidities not motivated to participate in psychosocial interventions targeting functioning after first-episode psychosis.
Twelve antipsychotics, including olanzapine, ziprasidone, and lurasidone, were examined in a meta-analysis.
Technique validation suggested a robust generalizability of neuroanatomical imaging in schizophrenia.
AVATAR therapy significantly reduced the severity of hallucinations compared with supportive counseling.
A schizophrenia-related polygenic-risk score association gradient was identified across bipolar disorder phenotypes.
The severity of psychotic symptoms in patients with bipolar affective disorder correlated inversely with the response to lithium therapy.
Patients with schizophrenia-spectrum disorders had higher odds of being aggressive than people with bipolar disorder with a recent manic episode.
For patients with schizophrenia or schizoaffective disorder, younger age was significantly associated with an increased rate of readmission.
The ability to track ingestion of medications prescribed for mental illness may be useful for some patients.
The risk of developing schizophrenia may be impacted by specific inflammatory biomarkers.
Transcranial direct current stimulation might aid patients with schizophrenia who experience auditory hallucinations.
Lurasidone reduced agitation in patients with acute exacerbation of schizophrenia.
People with schizophrenia have a mortality rate 3 times higher than the general population, which may be linked to higher rates of smoking, alcohol consumption, poor diet, and lack of exercise in people with schizophrenia.
The quality of diabetes care was examined in patients with and without schizophrenia in a Danish nationwide cohort.
In patients with schizophrenia, long-acting injectable formulations of paliperidone palmitate delay relapse significantly after withdrawal.
Dopamine dysfunction underlies the pathoetiology of psychosis in both bipolar disorder and schizophrenia.
Researchers conducted a prospective case-control study to examine predictors of early and late-onset psychosis in Parkinson disease.
These findings suggest that there are critical periods of development associated with a higher risk of persistent negative symptoms.
In this study, 672 patients with schizophrenia were evaluated with the EPICOG-SCH brief cognitive battery.
Seven signs and symptoms might alert someone to the possible presentation of schizophrenia.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
The FDA issued a refusal to file letter for a new drug application.
Switching therapy to Aristada resulted in statistically significant and clinically meaningful improvement in schizophrenia symptoms.
Adding telmisartan to treatment with olanzapine or clozapine may improve symptoms of schizophrenia.
Researchers from the University of Texas Southwestern Medical Center have discovered the cellular receptor that causes weight gain from antipsychotic drugs.
Long-term treatment of schizophrenia with cariprazine was found to be both safe and well-tolerated.
The FDA has approved Austedo.
Children and adolescent offspring of patients with schizophrenia demonstrate more attenuated psychotic symptoms.
Glucose tolerance and body mass index in patients with schizophrenia were improved by liraglutide.
Patients with schizophrenia in the MIN-101 trial demonstrated lower negative factor scores than a placebo group.
Impaired recollection could be a vulnerability marker for schizophrenia, whereas impaired social context memory could be a disease-related marker.
Schizophrenia treatment with long-acting injectable antipsychotic agents resulted in lower rehospitalization rates.
Clozapine-induced gastrointestinal hypomotility is a medical emergency that requires urgent attention.
A high percentage of patients were persistent and adherent to their PP3M treatment.
Clozapine might lower risk of self-harm for patients with treatment-resistant schizophrenia.
HIV, hepatitis B and hepatitis C are more common among patients with mental illnesses.
Interventions targeted at improving medication adherence might mitigate adverse effects of cannabis use on psychosis outcomes.
Long-acting injectables should be considered earlier in the treatment of schizophrenia.
Child maltreatment is significantly more prevalent in young individuals who present with UHR symptoms compared with controls.
Increases in autonomic function may predict the occurrence and severity of auditory hallucinations in patients with schizophrenia, suggesting a regulation of these experiences by the autonomic nervous system.
Diabetes mellitus (DM) appears to be more prevalent in the psychiatric setting than in the general population.
The risk for rehospitalization was 22% lower during treatment with long-acting injectable antipsychotic medications compared with treatment with equivalent oral formulations in the total cohort.
Schizophrenia patients may benefit from a a specific type of talk therapy, according to a new study from the University of Pennsylvania.
Concomitant SSRI/SNRI use was associated with an increased diabetes risk in AAP-treated young people.
There is currently no approved drug combination for treatment-resistant schizophrenia.
In patients with schizophrenia being treated with clozapine or olanzapine, liraglutide significantly improved glucose tolerance, body weight, and other cardiometabolic disturbances.
Electroconvulsive therapy can be a clinically effective treatment for patients with severe forms of schizophrenia.
Emotional stability assessed in late adolescence is inversely associated with serious mental illness.
Long-term valbenazine may be beneficial in managing tardive dyskinesia.
Body mass index in patients with schizophrenia is linked to C-reactive protein.
Schizophrenia outpatients were examined in this 52-week open-label extension trial.
Lurasidone is an atypical antipsychotic that has demonstrated efficacy in the treatment of schizophrenia in adolescents.
Dopamine-blocking antipsychotics are ineffective right from the onset of illness.
Mental disorders and psychotropic medication use are associated with an increased risk for fracture but are not fully captured by FRAX tool.
Schizophrenia was perceived as more distressful and with higher perceived social stigma than other disorders.
Scientists researched the association between multiple drug treatments for psychotic disorders and anticholinergic burden.
Ingrezza significantly and rapidly improved tardive dyskinesia symptoms compared to placebo, rmarking a tremendous breakthrough for patients suffering from TD.
Cannabis is the most widely misused illicit drug.
Schizophrenia was associated with 13 to 15 years of potential life lost.
The risk for offspring's development of psychosis is connected to maternal weight gain during pregnancy.
A trial at 3 mental health centers in The Netherlands revealed that patients with financial incentives have better compliance.
Participants in the risperidone group were generally more likely to achieve a significant clinical improvement in their mental state.
Cariprazine treatment led to greater improvement in the negative symptoms of schizophrenia than risperidone.
Adding high-dose B vitamins to traditional antipsychotic treatments reduces schizophrenia symptoms more than traditional treatments alone.
The FDA has approved a new treatment for adolescents between the ages of 13 and 17 years who are diagnosed with schizophrenia.
Researchers profiled which young people may do well after first-episode psychosis without medication.
These study results indicate that early intervention with low doses of metformin in patients with few metabolic abnormalities may be beneficial.
Targeting negative symptoms in patients with schizophrenia may be more effective in improving patients' QoL.
Pretreatment cardiometabolic status to be taken into consideration for treatment of first episode psychosis.
Inability to interpret facial expressions may exacerbate psychotic symptoms, either indirectly via social defeat or directly by creating confusing interpersonal experiences.
Cardiac safety is integral to child and adolescent antipsychotic therapy.
Patients with early schizophrenia may have already started down the road to diabetes, even prior to actual diagnosis.
Both immediate and gradual discontinuation of the current antipsychotic medication are viable treatment options.
Clinical practice guidelines are important resources for early intervention in a first episode of schizophrenia.
Young patients with first-episode psychosis may be able to achieve recovery.
This case offers evidence of the interaction between ciprofloxacin and clozapine.
Combined cognitive therapy and mindfulness can have lasting positive effects on behavior and mood.
Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading.
PUFA supplementation offers little additional aid to psychosis when good psychosocial care is already sought.
Hyperprolactinemia should be monitored during long-term risperidone treatment.
Sunovion have announced positive results from a study evaluating Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years old.
40-Hz ASSR spectral power and phase-locking deficits could be useful probes for assessing circuit dysfunctions in the disorder.
The findings might help to explain the increased prevalence of type 2 diabetes in patients with schizophrenia.
Studying cognition deficits during the clinical high risk period allows researchers to observe cognitive defects before chronicity and long-term medication use obscure the core deficits.
Medications used to treat addiction cut the risk of reoffending in half.
Indicators of schizophrenia, obsessive-compulsive disorder, and anxiety might be spotted in physical symptoms at age 18.
The Effect of Cognitive Remediation Training on Functional Connectivity and Social Cognition in Schizophrenia
Study provides further evidence for the effects of cognitive enhancement intervention on brain functional connectivity and cognitive performance in patients with schizophrenia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Researchers Identify Novel Potential Biomarkers for Autism
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Triiodothyronine in the Treatment of Bipolar Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Triiodothyronine in the Treatment of Bipolar Depression
- Suicide Risk After Self-Harm Among Adolescents, Young Adults
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Safety, Efficacy of Deep Brain Stimulation for Alzheimer Disease Examined
- Many Teens Who Use Tobacco Don't Self-Identify as Users